VEYVONDI subst sèche 1300 UI c solv set

7680666010020 CH-66601 B02BD10 06.01.1.

Reimbursement limitations:

BLUTPRODUKTE

Calcul des prix des préparations sanguines sur la base du prix « ex factory », …

VEYVONDI subst sèche 1300 UI c solv set
google

Details

Product number
6660102
CPT
-
Packaging group
1300 IE
Unit
Set
Composition
Praeparatio cryodesiccata: vonicogum alfa 1300 U.I., natrii citras dihydricus cum natrium 10.34 mg, mannitolum, trehalosum dihydricum, glycinum, polysorbatum 80 pro vitro. Solvens: aqua ad iniectabile.

Articles (1)

VEYVONDI 1300 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1300 IE
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/04/2024
Professional SmPC
Français
25/04/2024
Professional SmPC
Italien
25/04/2024

Detailed composition

Substance Quantity Type Category
SOLV
- Substance HNIDK
PRC
1300.0 UI Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
10.34 MG Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 978.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2019

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
66601
Drug name
VEYVONDI, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMJ
ATC Code
B02BD10
Authorization status
Z
Dispensation category
B
First authorization
04/10/2018
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Von-Willebrand-Krankheit

Packaging details

Description (FR)
VEYVONDI subst sèche 1300 UI c solv set
Description (DE)
VEYVONDI Trockensub 1300 IE c Solv Set
Market launch
04/10/2018
Narcotic (BTM)
No

Other packaging sizes

VEYVONDI subst sèche 650 UI c solv set
650 IE SET
View